WO1996032137A2
(en)
*
|
1995-04-14 |
1996-10-17 |
The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Methods of inducing immune tolerance using immunotoxins
|
US7696338B2
(en)
|
1995-10-30 |
2010-04-13 |
The United States Of America As Represented By The Department Of Health And Human Services |
Immunotoxin fusion proteins and means for expression thereof
|
US7517527B2
(en)
|
1995-10-30 |
2009-04-14 |
The United States Of America As Represented By The Department Of Health And Human Services |
Immunotoxin with in vivo T cell suppressant activity and methods of use
|
US7288254B2
(en)
|
1995-10-30 |
2007-10-30 |
The United States Of America As Represented By The Secretary, Department Of Health And Human Services, Nih |
Use of immunotoxins to induce immune tolerance to pancreatic islet transplantation
|
US7125553B1
(en)
|
1996-04-15 |
2006-10-24 |
The United States of America as represented by the Department of Health and Human Services c/o Centers for Disease Control and Prevention |
Methods of inducing immune tolerance using immunotoxins
|
CA2284079C
(en)
|
1997-03-05 |
2009-05-12 |
David M. Neville |
Immunotoxins and methods of inducing immune tolerance
|
WO1998039425A2
(en)
*
|
1997-03-05 |
1998-09-11 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Vectors and methods for expression of mutant proteins
|
US6676943B1
(en)
|
1997-04-24 |
2004-01-13 |
Regents Of The University Of Minnesota |
Human complement C3-degrading protein from Streptococcus pneumoniae
|
CN1086945C
(zh)
*
|
1997-06-03 |
2002-07-03 |
胡章英 |
白喉口服液
|
GB9923060D0
(en)
*
|
1999-09-29 |
1999-12-01 |
Chiron Spa |
Vaccine
|
MX339524B
(es)
*
|
2001-10-11 |
2016-05-30 |
Wyeth Corp |
Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
|
GB0211118D0
(en)
*
|
2002-05-15 |
2002-06-26 |
Polonelli Luciano |
Vaccines
|
AU2003257003A1
(en)
*
|
2002-07-30 |
2004-02-16 |
Baxter Healthcare S.A. |
Chimeric multivalent polysaccharide conjugate vaccines
|
US7785608B2
(en)
*
|
2002-08-30 |
2010-08-31 |
Wyeth Holdings Corporation |
Immunogenic compositions for the prevention and treatment of meningococcal disease
|
US7301554B2
(en)
*
|
2002-09-20 |
2007-11-27 |
Ricoh Company, Ltd. |
Light scanning device, scanning line adjusting method, scanning line adjusting control method, image forming apparatus, and image forming method
|
TWI357414B
(en)
|
2003-12-17 |
2012-02-01 |
Wyeth Llc |
Aβ immunogenic peptide carrier conjugates and meth
|
SI1701968T1
(sl)
|
2003-12-17 |
2015-08-31 |
Wyeth Llc |
Imunogeni konjugati peptidnih nosilcev in postopek izdelave istih
|
GB0505996D0
(en)
|
2005-03-23 |
2005-04-27 |
Glaxosmithkline Biolog Sa |
Fermentation process
|
AU2006235013B2
(en)
|
2005-04-08 |
2011-11-03 |
Wyeth Llc |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
US7709001B2
(en)
|
2005-04-08 |
2010-05-04 |
Wyeth Llc |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
TW200806315A
(en)
|
2006-04-26 |
2008-02-01 |
Wyeth Corp |
Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
|
US8808707B1
(en)
|
2006-05-08 |
2014-08-19 |
Wyeth Llc |
Pneumococcal dosing regimen
|
EA015863B1
(ru)
*
|
2006-05-31 |
2011-12-30 |
Сильвио Буцци |
Фармацевтическое применение белковых молекул, иммунологически взаимосвязанных с дифтерийным токсином
|
AR064642A1
(es)
|
2006-12-22 |
2009-04-15 |
Wyeth Corp |
Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
|
CN101265288B
(zh)
*
|
2007-03-13 |
2012-03-21 |
齐鲁制药有限公司 |
Crm197突变体的纯化方法
|
DK2424562T3
(en)
|
2009-04-30 |
2015-12-07 |
Coley Pharm Group Inc |
Pneumococcal vaccine and uses thereof
|
CA2766418C
(en)
|
2009-06-22 |
2016-03-29 |
Wyeth Llc |
Compositions and methods for preparing staphylococcus aureus serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions
|
HUE036372T2
(hu)
|
2009-06-22 |
2018-07-30 |
Wyeth Llc |
Staphylococcus aureus antigének immunogén készítményei
|
IT1398927B1
(it)
|
2009-06-25 |
2013-03-28 |
Consorzio Interuniversitario Per Lo Sviluppo Dei Sistemi A Grande Interfase Csgi |
Espressione batterica di un gene artificiale per la produzione di crm197 e derivati.
|
AU2010201410B2
(en)
*
|
2010-03-30 |
2015-04-30 |
Pelican Technology Holdings, Inc. |
High level expression of recombinant CRM197
|
CA2793978C
(en)
|
2010-03-30 |
2021-08-03 |
Pfenex Inc. |
High level expression of recombinant toxin proteins
|
BR112012030950B1
(pt)
|
2010-06-04 |
2020-02-04 |
Wyeth Llc |
composição imunogênica multivalente, formulação, frasco, dispositivo de distribuição de vacinas pré-enchido, kit, e recipiente
|
CA2800774A1
(en)
|
2010-06-07 |
2011-12-15 |
Pfizer Vaccines Llc |
Ige ch3 peptide vaccine
|
PL3246044T3
(pl)
|
2010-08-23 |
2021-08-23 |
Wyeth Llc |
Stabilne preparaty antygenów rLP2086 Neisseria meningitidis
|
CA2809758C
(en)
|
2010-09-10 |
2021-07-13 |
Wyeth Llc |
Non-lipidated variants of neisseria meningitidis orf2086 antigens
|
JP6048845B2
(ja)
|
2011-06-01 |
2016-12-21 |
シャモン ユニヴァーシティー |
ジフテリア毒素の無毒性突然変異体crm197又はその断片を含む融合タンパク質
|
SA115360586B1
(ar)
|
2012-03-09 |
2017-04-12 |
فايزر انك |
تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
|
CN104334187B
(zh)
|
2012-03-09 |
2017-04-05 |
辉瑞公司 |
脑膜炎双球菌组合物及其方法
|
US9169304B2
(en)
|
2012-05-01 |
2015-10-27 |
Pfenex Inc. |
Process for purifying recombinant Plasmodium falciparum circumsporozoite protein
|
KR102057217B1
(ko)
|
2012-06-20 |
2020-01-22 |
에스케이바이오사이언스 주식회사 |
다가 폐렴구균 다당류-단백질 접합체 조성물
|
US9777076B2
(en)
|
2012-07-16 |
2017-10-03 |
Pfizer Inc. |
Saccharides and uses thereof
|
CN102766647A
(zh)
*
|
2012-07-25 |
2012-11-07 |
天津康希诺生物技术有限公司 |
在白喉杆菌中稳定复制的表达载体及含该载体的白喉杆菌
|
AU2013303826B2
(en)
|
2012-08-16 |
2017-06-29 |
Pfizer Inc. |
Glycoconjugation processes and compositions
|
US9855325B2
(en)
|
2012-10-03 |
2018-01-02 |
Glaxosmithkline Biologicals Sa |
Immunogenic composition
|
KR20140075201A
(ko)
|
2012-12-11 |
2014-06-19 |
에스케이케미칼주식회사 |
다가 폐렴구균 다당류-단백질 접합체 조성물
|
KR20140075196A
(ko)
|
2012-12-11 |
2014-06-19 |
에스케이케미칼주식회사 |
다가 폐렴구균 다당류-단백질 접합체 조성물
|
EP4169929A1
(de)
|
2012-12-20 |
2023-04-26 |
Pfizer Inc. |
Immunogene zusammensetzungen mit pn-serotype 12f
|
US10517936B2
(en)
|
2013-01-04 |
2019-12-31 |
OBI Pharma., Inc. |
Vaccines with higher carbohydrate antigen density and novel saponin adjuvant
|
JP6446377B2
(ja)
|
2013-03-08 |
2018-12-26 |
ファイザー・インク |
免疫原性融合ポリペプチド
|
US9707153B2
(en)
|
2013-04-24 |
2017-07-18 |
Corning Incorporated |
Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
|
CN104140972B
(zh)
*
|
2013-05-07 |
2018-01-23 |
上海惠盾生物技术有限公司 |
白喉毒素突变体crm197的制备方法
|
EP3038979B1
(de)
|
2013-08-26 |
2019-04-17 |
Corning Incorporated |
Verfahren zum örtlichen entspannen von verstärktem glas
|
CN105492021B
(zh)
|
2013-09-08 |
2018-12-04 |
辉瑞公司 |
脑膜炎奈瑟氏球菌组合物及其方法
|
WO2015095868A1
(en)
|
2013-12-20 |
2015-06-25 |
Wake Forest University Health Sciences |
Methods and compositions for increasing protective antibody levels induced by pneumococcal polysaccharide vaccines
|
BR122023022294A2
(pt)
|
2014-01-21 |
2023-12-12 |
Pfizer Inc. |
Uso de uma composição imunogênica que compreende um conjugado imunogênico compreendendo um polissacarídeo capsular isolado de streptococcus pneumoniae do sorotipo 15b
|
US10105431B2
(en)
|
2014-01-21 |
2018-10-23 |
Pfizer Inc. |
Streptococcus pneumoniae capsular polysaccharides and conjugates thereof
|
US11160855B2
(en)
|
2014-01-21 |
2021-11-02 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
MX2016009470A
(es)
|
2014-01-21 |
2017-01-18 |
Pfizer |
Composiciones inmunogenicas que comprenden antigenos sacaridos capsulares conjugados y usos de los mismos.
|
WO2015117093A1
(en)
|
2014-01-31 |
2015-08-06 |
Fina Biosolutions, Llc |
Expression and purification of crm197 and related proteins
|
JP2017505792A
(ja)
|
2014-02-14 |
2017-02-23 |
ファイザー・インク |
免疫原性糖タンパク質コンジュゲート
|
US9815886B2
(en)
|
2014-10-28 |
2017-11-14 |
Adma Biologics, Inc. |
Compositions and methods for the treatment of immunodeficiency
|
JP2017538444A
(ja)
|
2014-11-20 |
2017-12-28 |
バイオロジカル イー リミテッド |
Crm197の高レベル発現のためにコドン最適化したポリヌクレオチド
|
US10653764B2
(en)
|
2015-01-15 |
2020-05-19 |
Pfizer Inc. |
Immunogenic compositions for use in pneumococcal vaccines
|
WO2016132294A1
(en)
|
2015-02-19 |
2016-08-25 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
EP3292146A1
(de)
|
2015-05-04 |
2018-03-14 |
Pfizer Inc |
Gruppe-b-streptococcus-polysaccharid-proteinkonjugate, verfahren zur herstellung von konjugaten, immunogene zusammensetzungen mit konjugaten und verwendungen davon
|
LT3313436T
(lt)
|
2015-06-23 |
2021-06-10 |
Biological E Limited |
Daugiavalentė pneumokokinė konjuguota vakcina
|
KR102225282B1
(ko)
|
2015-07-21 |
2021-03-10 |
화이자 인코포레이티드 |
접합된 캡슐형 사카라이드 항원을 포함하는 면역원성 조성물, 그를 포함하는 키트 및 그의 용도
|
CA3005524C
(en)
|
2015-11-20 |
2023-10-10 |
Pfizer Inc. |
Immunogenic compositions for use in pneumococcal vaccines
|
US11965009B2
(en)
|
2016-03-10 |
2024-04-23 |
The Johns Hopkins University |
Methods of producing aggregate-free monomeric diphtheria toxin fusion proteins and therapeutic uses
|
US11203626B2
(en)
|
2016-03-10 |
2021-12-21 |
The Johns Hopkins University |
Methods of producing aggregate-free monomeric diphtheria toxin fusion proteins and therapeutic uses
|
EP3426785A4
(de)
|
2016-03-10 |
2019-12-25 |
The Johns Hopkins University |
Verfahren zur herstellung von aggregatfreien monomeren diphtherietoxinfusionsproteinen und therapeutische verwendungen
|
EP3269385A1
(de)
|
2016-07-12 |
2018-01-17 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Pneumokokken-polysaccharid-proteinkonjugatzusammensetzung
|
US11191822B2
(en)
|
2016-06-22 |
2021-12-07 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Pneumococcal polysaccharide-protein conjugate composition
|
CN109862908B
(zh)
|
2016-08-05 |
2023-05-02 |
圣诺菲·帕斯图尔公司 |
多价肺炎球菌多糖-蛋白质缀合物组合物
|
US11224652B2
(en)
|
2016-08-05 |
2022-01-18 |
Sanofi Pasteur Inc. |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
UA126385C2
(uk)
|
2016-09-30 |
2022-09-28 |
Байолоджикал І Лімітед |
Композиції полівалентної пневмококової вакцини, що містять кон'югати полісахарид-білок
|
US10751402B2
(en)
|
2016-11-09 |
2020-08-25 |
Pfizer Inc. |
Immunogenic compositions and uses thereof
|
US11951165B2
(en)
|
2016-12-30 |
2024-04-09 |
Vaxcyte, Inc. |
Conjugated vaccine carrier proteins
|
EP3562503A2
(de)
|
2016-12-30 |
2019-11-06 |
Sutrovax, Inc. |
Polypeptid-antigen-konjugate mit nichtnatürlichen aminosäuren
|
EP3570879B1
(de)
|
2017-01-20 |
2022-03-30 |
Pfizer Inc. |
Immunogene zusammensetzung zur verwendung als pneumokokken-impfstoff
|
IL303108B1
(en)
|
2017-01-31 |
2024-03-01 |
Pfizer |
NEISSERIA MENINGITIDIS preparations and methods therefor
|
EP3576759A4
(de)
|
2017-01-31 |
2020-11-11 |
Merck Sharp & Dohme Corp. |
Verfahren zur herstellung von kapselpolysaccharidproteinkonjugaten aus streptococcus pneumoniae serotyp 19f
|
KR101908590B1
(ko)
|
2017-02-01 |
2018-10-16 |
(주)포바이오코리아 |
Crm197의 용해성 단백질 발현 및 정제 방법
|
CA3052621A1
(en)
|
2017-02-03 |
2018-08-09 |
Schadeck, Eva Barbara |
Haemophilus influenzae saccharide-carrier conjugate compositions and uses thereof
|
US10259865B2
(en)
|
2017-03-15 |
2019-04-16 |
Adma Biologics, Inc. |
Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
|
MX2019012563A
(es)
|
2017-04-22 |
2019-12-02 |
Biological E Ltd |
Un metodo mejorado para la alta produccion de crm.
|
JP7438102B2
(ja)
|
2017-09-07 |
2024-02-26 |
メルク・シャープ・アンド・ドーム・エルエルシー |
肺炎球菌多糖体および免疫原性多糖体-キャリアタンパク質コンジュゲートでのその使用
|
CN111683678B
(zh)
|
2017-12-06 |
2024-01-26 |
默沙东有限责任公司 |
包含肺炎链球菌多糖蛋白缀合物的组合物及其使用方法
|
KR102475419B1
(ko)
*
|
2018-07-16 |
2022-12-07 |
주식회사 유바이오로직스 |
Crm197을 고농도로 발현하는 코리네박테리움 균주
|
US11260119B2
(en)
|
2018-08-24 |
2022-03-01 |
Pfizer Inc. |
Escherichia coli compositions and methods thereof
|
CN109100517A
(zh)
*
|
2018-10-08 |
2018-12-28 |
武汉生命科技股份有限公司 |
一种用于检测白喉抗体的抗原蛋白、试剂盒及制备方法
|
CA3120922A1
(en)
|
2018-12-12 |
2020-06-18 |
Pfizer Inc. |
Immunogenic multiple hetero-antigen polysaccharide-protein conjugates and uses thereof
|
CA3123414A1
(en)
|
2018-12-19 |
2020-06-25 |
Merck Sharp & Dohme Corp. |
Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
|
JP7239509B6
(ja)
|
2019-02-22 |
2023-03-28 |
ファイザー・インク |
細菌多糖類を精製するための方法
|
US20220184199A1
(en)
|
2019-04-10 |
2022-06-16 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof
|
JP2022542316A
(ja)
|
2019-07-31 |
2022-09-30 |
サノフィ パスツール インコーポレイテッド |
多価肺炎球菌多糖体-タンパク質コンジュゲート組成物およびその使用方法
|
EP4051696A1
(de)
|
2019-11-01 |
2022-09-07 |
Pfizer Inc. |
Escherichia-zusammensetzungen und verfahren dafür
|
BR112022015796A2
(pt)
|
2020-02-21 |
2022-10-11 |
Pfizer |
Purificação de sacarídeos
|
CA3173729A1
(en)
|
2020-02-23 |
2021-08-26 |
Pfizer Inc. |
Escherichia coli compositions and methods thereof
|
EP3900739A1
(de)
|
2020-04-21 |
2021-10-27 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Synthetische streptococcus-pneumoniae-saccharid-konjugate zum konservierten membranprotein
|
EP3919076A1
(de)
|
2020-06-02 |
2021-12-08 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Synthetische oligosaccharidimpfstoffe gegen streptococcus pneumoniae mit mikropartikel-adjuvans-formulierungen
|
WO2022043855A1
(en)
|
2020-08-26 |
2022-03-03 |
Pfizer Inc. |
Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
|
KR20230043157A
(ko)
|
2020-09-17 |
2023-03-30 |
얀센 파마슈티칼즈, 인코포레이티드 |
다가 백신 조성물 및 이의 용도
|
WO2022084852A1
(en)
|
2020-10-22 |
2022-04-28 |
Pfizer Inc. |
Methods for purifying bacterial polysaccharides
|
MX2023004912A
(es)
|
2020-10-27 |
2023-05-16 |
Pfizer |
Composiciones de escherichia coli y metodos de las mismas.
|
EP4240410A1
(de)
|
2020-11-04 |
2023-09-13 |
Pfizer Inc. |
Immunogene zusammensetzungen zur verwendung in pneumokokkenimpfstoffen
|
EP4243863A2
(de)
|
2020-11-10 |
2023-09-20 |
Pfizer Inc. |
Immunogene zusammensetzungen mit konjugierten kapselsaccharidantigenen und verwendungen davon
|
US20220202923A1
(en)
|
2020-12-23 |
2022-06-30 |
Pfizer Inc. |
E. coli fimh mutants and uses thereof
|
KR20220102871A
(ko)
|
2021-01-14 |
2022-07-21 |
(주)셀트리온 |
다가 폐렴구균 다당류-단백질 접합체를 포함하는 면역원성 조성물
|
TW202245835A
(zh)
|
2021-02-04 |
2022-12-01 |
美商默沙東有限責任公司 |
用於肺炎球菌結合物疫苗之奈米乳化液佐劑組合物
|
WO2022234416A1
(en)
|
2021-05-03 |
2022-11-10 |
Pfizer Inc. |
Vaccination against pneumoccocal and covid-19 infections
|
JP2024517780A
(ja)
|
2021-05-03 |
2024-04-23 |
ファイザー・インク |
細菌およびベータコロナウイルス感染症に対するワクチン接種
|
US20220387613A1
(en)
|
2021-05-28 |
2022-12-08 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
TW202306969A
(zh)
|
2021-05-28 |
2023-02-16 |
美商輝瑞大藥廠 |
包含結合之莢膜醣抗原的免疫原組合物及其用途
|
WO2023135515A1
(en)
|
2022-01-13 |
2023-07-20 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
WO2023161817A1
(en)
|
2022-02-25 |
2023-08-31 |
Pfizer Inc. |
Methods for incorporating azido groups in bacterial capsular polysaccharides
|
WO2023218322A1
(en)
|
2022-05-11 |
2023-11-16 |
Pfizer Inc. |
Process for producing of vaccine formulations with preservatives
|
WO2024084397A1
(en)
|
2022-10-19 |
2024-04-25 |
Pfizer Inc. |
Vaccination against pneumoccocal and covid-19 infections
|
WO2024089001A1
(en)
|
2022-10-24 |
2024-05-02 |
Idorsia Pharmaceuticals Ltd |
Vaccine against klebsiella pneumoniae
|
WO2024110827A1
(en)
|
2022-11-21 |
2024-05-30 |
Pfizer Inc. |
Methods for preparing conjugated capsular saccharide antigens and uses thereof
|
WO2024110839A2
(en)
|
2022-11-22 |
2024-05-30 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
WO2024116096A1
(en)
|
2022-12-01 |
2024-06-06 |
Pfizer Inc. |
Pneumococcal conjugate vaccine formulations
|
WO2024121280A1
(en)
|
2022-12-08 |
2024-06-13 |
Idorsia Pharmaceuticals Ltd |
Vaccine against klebsiella pneumoniae
|